According to a recent LinkedIn post from TandemStride, the company is adding R.J. Briscione as its new Head of Growth. The post highlights his prior roles at CVS Health, Anthem, and Centene, where he worked on Medicaid, social needs, and member engagement programs focused on non-medical drivers of outcomes.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests that TandemStride is targeting a structural gap in care following traumatic injuries, particularly for Medicaid populations. It describes missed follow-ups, untreated mental health needs, and weak links to community resources as areas the company aims to address with a dedicated “recovery infrastructure.”
As shared in the post, Briscione is expected to focus on engaging health plans and trauma systems as the firm expands. For investors, this senior hire may signal an intention to scale payer and provider partnerships nationally, which could be a key driver of revenue growth if TandemStride can demonstrate improved outcomes and cost savings for vulnerable populations.
The CEO’s quoted comments in the post emphasize that existing health systems are strong on acute life-saving care but lack post-discharge support. This framing points to a value proposition centered on reducing costly readmissions and improving long-term recovery, positioning TandemStride within the broader healthcare innovation and managed care ecosystem.
While the post does not provide financial metrics, timelines, or specific contracts, the emphasis on nationwide partnerships indicates a go-to-market strategy reliant on collaboration with large health plans and trauma networks. Successful execution of this strategy could enhance the company’s competitive position in Medicaid-focused care coordination and trauma recovery services.